Clinical Trial Update: A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and immune response of Novartis' meningococcal ACWY vaccine in infants has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease
• Meningococcal Meningitis

Drugs mentioned

• Novartis Meningococcal ACWY Vaccine

Snippet

Sponsor: Novartis Vaccines | Conditions: Meningitis, Meningococcal | Phase 3 | Status: COMPLETED | Results posted: 2014-03-24